Acanna Therapeutics, Inc. — Form D

Acanna Therapeutics, Inc. of NAPLES, FL, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-20. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2022-05-20
• Form: D
• Accession: 0001929743-22-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $1.0M
• Remaining: $4.0M
• Investors: 1
• Date of first sale: 2022-05-05
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-446471

Issuer

• Name: Acanna Therapeutics, Inc.
• CIK: 0001929743
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 4851 TAMIAMI TRAIL N, NAPLES, FL, 34103
• Phone: 403-605-8747

Officers, directors & promoters (2)

More

• CIK 1929743 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search